Literature DB >> 17269188

The diagnostic "gold standard" in oncology: increasing importance and increasing concerns.

Maurie Markman.   

Abstract

Mesh：

Year:  2006        PMID： 17269188     DOI： 10.1007/s11912-006-0025-5

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  15 in total

1.  Pathologic diagnosis as the gold standard.

Authors:  L B Rorke
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

2.  Prostate cancer and the Will Rogers phenomenon.

Authors:  Peter C Albertsen; James A Hanley; George H Barrows; David F Penson; Pam D H Kowalczyk; M Melinda Sanders; Judith Fine
Journal:  J Natl Cancer Inst       Date:  2005-09-07       Impact factor: 13.506

3.  Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma.

Authors:  I Vergote; J De Brabanter; A Fyles; K Bertelsen; N Einhorn; P Sevelda; M E Gore; J Kaern; H Verrelst; K Sjövall; D Timmerman; J Vandewalle; M Van Gramberen; C G Tropé
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

4.  Diagnostic discrepancies and their clinical impact in a neuropathology referral practice.

Authors:  J M Bruner; L Inouye; G N Fuller; L A Langford
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

5.  Natural history and prognosis of untreated stage I epithelial ovarian carcinoma.

Authors:  F Y Ahmed; E Wiltshaw; R P A'Hern; B Nicol; J Shepherd; P Blake; C Fisher; M E Gore
Journal:  J Clin Oncol       Date:  1996-11       Impact factor: 44.544

6.  Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential.

Authors:  Ivo Meinhold-Heerlein; Dirk Bauerschlag; Felix Hilpert; Petre Dimitrov; Lisa M Sapinoso; Marzenna Orlowska-Volk; Thomas Bauknecht; Tjoung-Won Park; Walter Jonat; Anja Jacobsen; Jalid Sehouli; Jutta Luttges; Maryla Krajewski; Stan Krajewski; John C Reed; Norbert Arnold; Garret M Hampton
Journal:  Oncogene       Date:  2005-02-03       Impact factor: 9.867

7.  Analysis of prognostic factors in stage I epithelial ovarian carcinoma: importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse.

Authors:  I B Vergote; J Kaern; V M Abeler; E O Pettersen; L N De Vos; C G Tropé
Journal:  Am J Obstet Gynecol       Date:  1993-07       Impact factor: 8.661

Review 8.  Systematic review of adjuvant care for women with Stage I ovarian carcinoma.

Authors:  Laurie Elit; Alexandra Chambers; Anthony Fyles; Allan Covens; Mark Carey; Michael Fung Kee Fung
Journal:  Cancer       Date:  2004-11-01       Impact factor: 6.860

9.  The influence of grade on the outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading.

Authors:  D M O'Connor; H J Norris
Journal:  Int J Gynecol Pathol       Date:  1994-10       Impact factor: 2.762

10.  Prognostic factors in patients with stage I epithelial ovarian cancer.

Authors:  A J Dembo; M Davy; A E Stenwig; E J Berle; R S Bush; K Kjorstad
Journal:  Obstet Gynecol       Date:  1990-02       Impact factor: 7.661
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.